Joined January 2011
- Tweets 4,190
- Following 55
- Followers 1,006
- Likes 341
1,051 Photos and videos
What if we've been overlooking a promising treatment for low #sexual desire in #men? Our new editorial and podcast revisits #bremelanotide (Vyleesi) for sexual desire and arousal disorders in men.
🎧 Podcast: jcpjournal.libsyn.com/should…
📜 Editorial: journals.lww.com/psychopharm…
91
A new international survey of healthcare providers found SSRIs remain the most common first-line treatment for MDD, while augmentation with atypical antipsychotics increases with greater illness severity and inadequate antidepressant response.
🔗Read more: journals.lww.com/psychopharm…
3
142
Why is it so hard to find psychiatrists well-trained in #psychopharmacology? Our recent editorial argues the problem isn’t just workforce shortages, but also gaps in residency training, supervision, and evaluation.
🎧 jcpjournal.libsyn.com/curren…
📜 journals.lww.com/psychopharm…
2
119
The CADET Trials are evaluating whether #candesartan, a commonly prescribed antihypertensive medication, may serve as a novel adjunctive treatment for bipolar and major depressive disorder by targeting the renin-angiotensin system.
Read more in JCP: 🔗 journals.lww.com/psychopharm…
272
New real-world evidence shows that adding GLP-1 receptor agonists to second-generation antipsychotic treatment in nondiabetic adults may do more than address weight gain – it may also improve adherence.
🔗Read more in our current issue: journals.lww.com/psychopharm…
1
2
1
133
In a large real-world study of #pediatric #PTSD, psychotherapy was underused, while antidepressants and antipsychotics were frequently prescribed, often without prior therapy. Significant racial and ethnic disparities were observed.
🔗Read more: journals.lww.com/psychopharm…
2
3
327
Our May/June 2026 issue (Volume 46, issue 3) is now available online: journals.lww.com/psychopharm…
Brief synopsis of the new issue from the Journal of Clinical Psychopharmacology Editor-in-Chief is below.
1
95
Findings from a new study show that #methylphenidate significantly reduces emotional impulsivity in medication-naive children with #ADHD without comorbidities, supporting its potential as a first-line treatment without the need for additional medications.
journals.lww.com/psychopharm…
126
Journal of Clinical Psychopharmacology retweeted
Alcohol Use Disorder treatment is evolving.
A new review explores the potential role of GLP‑1 receptor agonists in supporting AUD care—highlighting how science continues to expand treatment options. ow.ly/LrE750YEBrh #AlcoholAwarenessMonth #AUDResearch @JCPjournal
1
1
81
In a new case report in JCP, semaglutide, a GLP-1 receptor agonist, was associated with sustained remission of gambling behavior in a patient with gambling disorder. This case highlights a potential new pharmacologic pathway targeting reward systems.
🔗 journals.lww.com/psychopharm…
2
2
123
Our new podcast explores trends in #tardive #dyskinesia diagnosis and use of #VMAT2 inhibitors among adults treated with #antipsychotics. The study finds #TD remains underdiagnosed and treatment rates remain low.
🎧Listen: jcpjournal.libsyn.com/the-us…
📜Read: journals.lww.com/psychopharm…
1
117
The Journal of Clinical Psychopharmacology is building a presence on Bluesky, and we’d love for our LinkedIn community to be part of it. Follow us on Bluesky Social for early updates, featured research, and insight into psychopharmacology trends. 📲 psychopharm.bsky.social
52
Why is it so hard to find psychiatrists well-trained in #psychopharmacology? Our new editorial argues the problem isn’t just workforce shortages, but also gaps in residency training, supervision, & evaluation.
🎧Podcast: jcpjournal.libsyn.com/curren…
📰Article: journals.lww.com/psychopharm…
1
129
#Akathisia remains a common and distressing adverse effect of #antipsychotics. In a double-blind randomized trial, cyproheptadine significantly improved symptoms compared with placebo within one week and was generally well tolerated.
🔗 Read more in JCP: journals.lww.com/psychopharm…
1
4
388
We’re pleased to share that Dr. Bennett Wechsler has been selected as the inaugural Editorial Fellow for JCP. Chosen from a highly competitive pool of outstanding applicants, he’ll be working with the editorial team to support the journal’s work. Congratulations, @Bwechsler_MD!
1
85
A new review examines #methylphenidate use in individuals without clinical conditions. Its findings suggest that methylphenidate may boost attention and reaction time, while effects on memory, mood, and inhibition remain inconsistent.
🔗Read more in JCP: journals.lww.com/psychopharm…
2
162
A new study in youth with #ASD found that #SGA use was not associated with higher #BMI. However, public insurance and disruptive behavior disorders were linked to increased risk of #weight gain, while #stimulant co-treatment may help mitigate it.
🔗journals.lww.com/psychopharm…
77
Our new podcast explores trends in #tardive #dyskinesia diagnosis and use of #VMAT2 inhibitors among adults treated with #antipsychotics. The study finds #TD remains underdiagnosed and treatment rates remain low.
🎧Listen: jcpjournal.libsyn.com/the-us…
📜Read: journals.lww.com/psychopharm…
1
179
Why is it so hard to find psychiatrists well-trained in #psychopharmacology? Our new editorial argues the problem isn’t just workforce shortages, but also gaps in residency training, supervision, & evaluation.
🎧Podcast: jcpjournal.libsyn.com/curren…
📰Article: journals.lww.com/psychopharm…
5
196
How much does patient profile really shape the #psychedelic experience? New data suggest that in adults with TRD, #psilocybin ##dose -- not baseline clinical characteristics -- was the strongest driver of the acute psychedelic experience.
🔗Read more: journals.lww.com/psychopharm…
1
85